Founded in 2007, Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. As a leader in the renal community, we leverage scientific expertise and commercial capabilities to deliver novel therapeutics to address the complications of kidney disease.
We are located in the biotech hub of Kendall Square in Cambridge, Massachusetts, where we are inspired by our peers and dedicated to working with our partners, patients, advocacy organizations and the broader renal community. We have both an experienced nephrology-focused commercial team and a robust development organization. We currently have two FDA- approved products.
Find out more about Akebia and our pursuits in anemia by visiting {www.akebia.com}
Brands: Find out more about Akebia and our pursuits in anemia by visiting {www.akebia.com}